• Archives of Plastic Surgery
• /
• 제33권5호
• /
• pp.659-662
• /
• 2006

Purpose: Alloplastic implants, such as methylmethacrylate, Teflon, silicone, Supramid are commonly used to cover the floor defect and to prevent reherniation of the displaced orbital tissue in orbital floor fracture. Silicone implant has been used for reconstruction of orbital wall defects because of pliability, advantage of carving and chemically inert nature. However, silicone implant also has complications including infection, extrusion, pain, dystopia and tissue reaction. Cyst formation around the silicone implant is a very rare complication. According to many reports, cysts around alloplastic implant in an orbital area are mostly hemorrhagic cysts consisted of blood breakdown product with fibrous capsule cell in histologic examination. Methods: The authors report atypical case and successful treatment of intraorbital hemorrhagic cyst around silicone implant of a 37-year-old male patient. Results: Preoperative symptoms of diplopia, exophthalmos, proptosis, vertical dystopia and ectropion of lower eyelid were resolved after surgical removal of implants with surrounding capsule. Conclusion: Clinical suspicion of plastic surgeon is important in diagnosis of intraorbital cyst of patients who have history of silicone implantation and computed tomography is the standard tool of diagnosis. During the operation, caution must be taken on delivering the whole capsule of intraorbital cyst along with silicone implant to prevent recurrence of the cyst.

• 약학회지
• /
• 제56권2호
• /
• pp.126-135
• /
• 2012

Purpose: To develop therapeutic duplication criteria for the drugs used for respiratory diseases. Method: Therapeutic duplication was defined as "more than 2 drug ingredient-usage in which each has the same therapeutic effect and combination therapy does not confer additional therapeutic benefit". Respiratory system drugs approved in Korea were examined for the study. The WHO's Anatomical Therapeutic Chemical Classification System was used for grouping of the corresponding drug ingredients. The principles and recommendations on combination usage or multiple drug regimens were reviewed by using the clinical practice guidelines, textbooks, product labelings, and clinical articles. Clinical expert group consultation was performed and expert opinions were incorporated into the final criteria. Results: Nine hundred sixty two drug products with Korean Food and Drug Administration classification codes of 141, 149, 222, and 229 were evaluated, of which 87 active ingredients were composed. The drug ingredients were classified into 12 groups (antihistamines, oral nasal decongestants, leukotriene receptor antagonists, inhaled anticholinergics, inhaled corticosteroids, oral ${\beta}2$-agonists, long-acting ${\beta}2$-agonists, short-acting ${\beta}2$-agonists, xanthines, antiallergics, mucolytics and cough suppressants). The use of more than 2 drug ingredients including the same group was therapeutic duplication, and thus combination should be recommended not to be used. Conclusion: Twelve drug groups were identified as therapeutic duplication criteria. Combination therapy within each group should not be used otherwise therapeutic benefits outweigh potential risks.

• 대한교통학회지
• /
• 제25권3호
• /
• pp.29-43
• /
• 2007

차량용 블랙박스는 교통사고 예방 및 원인 규명을 위해 충분한 정보를 제공하고, 그 정보 데이터베이스는 개인의 사생활 침해를 최소화하는 범위에서 적절하게 공개되어 전 국민에게 다양한 서비스를 제공할 수 있다. 따라서 차량용 블랙박스는 정부 기관이나 보험 업체뿐만 아니라 관련 업계 전체에 긍정적 파급 효과가 큰 지능형 요소 부품이다. 본 논문에서는 차량용 블랙박스의 도입이 추진되고 있는 현 상황에서 차량용 블랙박스의 기술적 내용과 국내외 기술 현황을 조사하고, 국내외에서 출원된 특허 분석을 통하여 차량용 블랙박스에 대한 특허 출원 현황 조사 결과와 핵심 특허 기술의 심층 분석 내용을 제시한다. 또한, 국내외에서 진행되고 있는 표준화/법제화 동향 등을 서술하고, 이에 대한 대응방안으로서 표준화 제정 및 블랙박스 제품기술 개발 방안들을 함께 제시한다.

• 한국임상약학회지
• /
• 제20권3호
• /
• pp.213-220
• /
• 2010

Therapeutic duplication (TD) is a serious problem that frequently occurring primarily in the ambulatory setting in Korea. Implementation of concurrent drug utilization review (DUR) is a promising way to reduce inappropriate prescription and dispensing, and improve patient safety. This study was aimed to develop the process of DUR module of TD. Sixty-five drug ingredients classified into the drug category of the antipyretic, analgesic, and anti-inflammatory drug approved in Korea (The KFDA-dess nated classification codes of 114 or 264) were reviewed for this purpose. The drug ingredients (and products) were reclassified based on WHO's Anatomical, Therapeutic and Chemical (ATC) classification system. The clinical practice guidelines, textbooks and product labels on therapeutic uses of these drugs in Korea and several fores n countries were reviewed. If the drugs were categorized into the same therapeutically duplicable class, they were defined not to be used concurrently because the concurrent use was "therapeutically duplicated (unnecessary or even harmful)". Among the studied drug products, the following 5 drug classes were considto beas "therapeutic duplication": (1), on-t tooid DURnti-inflammatory drugs (NSAIDs, including s Dicylates), (2),Anilidts, (3),Opioids, (4) Ergot Dk Doids and (5) 5-$HT_1$ receptor agonot s. Therefore, concurrent prescribing or dispensing of more than 2 drug ingredients any in the above same classes should be considered as TD and needed to be warrant for careful review by pharmacists before dispensing.

• Journal of Forest and Environmental Science
• /
• 제28권2호
• /
• pp.118-136
• /
• 2012

Investigation of flora was performed from March to October of 2008 as Eastern and Western coastal districts located in the same latitude ($36^{\circ}47^{\prime}-37^{\circ}48^{\prime}$), in order to apply this to basic data for effective protection and management of coastal forests also for insurance of biodiversity in coastal forests. As a result of the investigation of floras, both coastal forests recorded product-plants as follows: 98 families, 262 genera, 370 species, 46 varieties, 4 forms, 1 hybrid, 421 taxa in total. The Eastern coastal forests had 85 families, 188 genus, 248 species, 32 varieties, 3 forms, 1 hybrid, 285 taxa in total, whereas Western coastal forest had 96 families, 227 genus, 306 species, 39 varieties, 2 forms, 1 hybrid, 348 taxa in total. Among them, seashore plants accounted for 10.2% of total plants appeared in both coastal, and they are 26 families, 38 genus, 40 species, 3 hybrids and 43 taxa in total. There are special Korea plants in both coastal; 9 families, 9 genus, 8 species, 1 varieties, 1 hybrid, 10 taxa in total. There are rare plants in both coastal; 8 families, 8 genus, 7 species, 1 varieties, 8 taxa in total. Naturalized plants are also existed; 11 families, 24 species, 1 variety, 30 taxa in total.

• 대한치과기공학회지
• /
• 제42권2호
• /
• pp.149-162
• /
• 2020

Purpose: The purpose of this study was to conduct a cost accounting of implant prosthesis according to the fabrication activities. Methods: In this study, the cost price of implant prosthesis fabrication activities was calculated by the bottom-up costing approach for material and labor cost and the top-down costing approach for expenses and other. Results: The total cost price was estimated to 220,000 ~ 310,000 won per one implant prosthesis. By product, the screw type was estimated to 220,000 ~ 230,000 won, and when the stent and tray were included, it was 260,000 ~ 270,000 won, which increased about 40,000 won. And, the cement type with more material and labor time was estimated to 250,000 ~ 260,000 won, and when the stent and tray were included, it was about 300,000 won. Conclusion: In terms of the fabrication cost ratio by items, it was shown that material cost and labor cost accounted for about 40% and 30% of the total cost structure for resin case, respectively, which was the opposite for porcelain. It was shown that expenses and general administrative expenses accounted for about 15%, and profits were about 11% ~ 14% in both cases.

• Journal of Preventive Medicine and Public Health
• /
• 제50권2호
• /
• pp.91-99
• /
• 2017

Objectives: As in many low-income and middle-income countries, out-of-pocket (OOP) payments by patients or their families are a key healthcare financing mechanism in Bangladesh that leads to economic burdens for households. The objective of this study was to identify whether and to what extent socioeconomic, demographic, and behavioral factors of the population had an impact on OOP expenditures in Bangladesh. Methods: A total of 12 400 patients who had paid to receive any type of healthcare services within the previous 30 days were analyzed from the Bangladesh Household Income and Expenditure Survey data, 2010. We employed regression analysis for identify factors influencing OOP health expenditures using the ordinary least square method. Results: The mean total OOP healthcare expenditures was US dollar (USD) 27.66; while, the cost of medicines (USD 16.98) was the highest cost driver (61% of total OOP healthcare expenditure). In addition, this study identified age, sex, marital status, place of residence, and family wealth as significant factors associated with higher OOP healthcare expenditures. In contrary, unemployment and not receiving financial social benefits were inversely associated with OOP expenditures. Conclusions: The findings of this study can help decision-makers by clarifying the determinants of OOP, discussing the mechanisms driving these determinants, and there by underscoring the need to develop policy options for building stronger financial protection mechanisms. The government should consider devoting more resources to providing free or subsidized care. In parallel with government action, the development of other prudential and sustainable risk-pooling mechanisms may help attract enthusiastic subscribers to community-based health insurance schemes.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권7호
• /
• pp.4329-4334
• /
• 2013

Background: Cervical cancer, which is common in developing countries, is also a major health issue in Korea. Our aim was to evaluate the cost-effectiveness of Korea's National Cancer Screening Program (NCSP), implemented in 1999. Materials and Methods: The target population was Korean women 30 years or over who were invited to take part in the NCSP in 2002-2007. By merging NCSP records with Korean Central Cancer Registry data, patients diagnosed with cervical cancer who had been screened were assigned to a "screened group," while patients diagnosed elsewhere were assigned to a "non-screened group." Clinical outcomes were measured in terms of life-years saved (LYS), derived from 5-year mortality rates supplied by the Korean National Health Insurance Corporation and National Statistical Office. Direct and travel costs associated with screening were evaluated from the perspective of the payer, the NCSP. Results: A diagnosis via screening was associated with 2.30 LYS, and the incremental cost-effectiveness ratio (ICER) estimate for screening was 7,581,679 KW/LYS (6,727 USD/LYS). ICER estimates were lower for older patients (${\geq}$ 50 years) than younger patients (4,047,033 KW/LYS vs 5,680,793 KW/LYS). The proportion of early-stage cancers detected was 16.3% higher in the screened group. Conclusions: In light of Korea's per capita gross domestic product (32,272 USD in 2012), the current NCSP's incremental cost per LYS appears acceptable.

• 보건행정학회지
• /
• 제26권2호
• /
• pp.95-106
• /
• 2016

A new manual of System of Health Accounts (SHA) 2011, was published jointly by the Organization for Economic Cooperation and Development (OECD), Eurostat, and World Health Organization in 2011. This offers more complete coverage than the previous version, SHA 1.0, within the functional classification in areas such as prevention and a precise approach for tracking financing in the health care sector using the new classification of financing schemes. This paper aims to demonstrate current health expenditure (CHE) and National Health Accounts of the years 1970-2014 constructed according to the SHA2011. Data sources for public financing include budget and settlement documents of the government, various statistics from the National Health Insurance, and others. In the case of private financing, an estimation of total revenue by provider groups is made from the Economic Census data and the household income and expenditure survey, Korean healthcare panel study, etc. are used to allocate those totals into functional classifications. CHE was 105 trillion won in 2014, which accounts for 7.1% of Korea's gross domestic product. It was a big increase of 7.7 trillion won, 7.9%, from the previous year. Public share (government and compulsory schemes) accounting for 56.5% of the CHE in 2014 was still much lower than the OECD average of about 73%. With these estimates, it is possible to compare health expenditures of Korea and other countries better. Awareness and appreciation of the need and gains from applying SHA2011 for the health expenditure classification are expected to increase as OECD health expenditure figures get more frequently quoted among health policy makers.

• Communications for Statistical Applications and Methods
• /
• 제16권2호
• /
• pp.249-264
• /
• 2009

지수연동형 보험상품(EIA: Equity-indexed annuities)은 주식시장의 수익률과 연계하여 보험상품의 수익률이 결정되며 주식시장의 수익률이 낮은 경우에도 최소보장 수익률이 제공되는 상품이다 EIA의 수익률은 주가 수익률에 일정 비율을 곱하고 이 값과 최소보장수익률과 비교하여 높은 값을 수익률로 정의한다. 여기서 주가수익률에 곱하는 일정비율을 참여율(Participation rate)이라고 부른다. 본 논문에서는 수익률을 결정하는 주가지수와 일정수준을 넘는 여부를 결정하는 주가지수를 다른 지수로 사용하는 Outside Barrier가 내재된 보험 상품을 제안하고자 한다. 특히 Outside Barrier조건의 결정을 계약기간 전체가 아닌 계약기간의 일부분으로 선정한 것이 특징이다. 이러한 수익률 구조를 반영하는 가격 공식을 기댓값 계산을 통하여 유도하고 수치해석 기법을 이용하여 최소보장이율, Rebate, barrier 수준, 주가 변동성, 상관계수 및 관측기간 등의 변수가 참여율의 결정 에 어떤 영향을 미치는지를 알아보고자 한다.